|
个人信息Personal Information
教授
博士生导师
硕士生导师
性别：男
毕业院校：中科院大连化学物理研究所
学位：博士
所在单位：化工海洋与生命学院
学科：药理学. 生物医学工程. 生物化学与分子生物学
办公地点：盘锦校区F03-312B
联系方式：
电子邮箱：
扫描关注
- [1]Xiao, Shichao.Yin, Hang,Lv, Xin,Wang, Zhen,姜丽丽,Xia, Yangliu,刘勇,Liu, Yong; Xia, Yangliu.Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis[J],BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,2024,90(9):2067-2078
- [2]Zhang, Nan.刘勇,Jeong, Hyunyoung.Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases[J],Scientific Reports,2022,5:17778
- [3]姜丽丽.Chen, Daoyu,Wang, Zhen,Zhang, Zhongmin,夏杨柳,薛宏宇,刘勇.Preparation of an Electrically Conductive Graphene Oxide/Chitosan Scaffold for Cardiac Tissue Engineering[J],APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY,2022,188(4):952-964
- [4]姜丽丽.刘勇,Wang, Zhe,Lv, Xin,Yin, Hang.范晓宇,贾艳艳,王潇宇,贾雅钦,冯钰益,阎明睿.Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis.[J],Expert opinion on drug safety,22(5):407-416
- [5]Lv, Xin.Wang, Zhe,Yin, Hang,夏杨柳,姜丽丽,刘勇.王珍.Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.[J],Toxicology and applied pharmacology,466:116490
- [6]Wang, Zhen.姜丽丽,Lv, Xin,Yin, Hang,Wang, Zhe,李文利,刘勇.Higher risk of hepatotoxicity associated with cabozantinib in cancer patients[J],CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,2024,196
- [7]Ye, Weiyi.Wang, Zhen,Lv, Xin,Yin, Hang,姜丽丽,Wang, Zhe,刘勇.Potential risk of drug-drug interactions of ponatinib via inhibition against human UDP-glucuronosyltransferases.[J],Toxicology in vitro : an international journal published in association with BIBRA,2024,92:105664
- [8]Du, Jie.Liu, Jing,Wang, Shujuan,Wang, Changyuan,Meng, Qiang,Sun, Huijun,Liu, Kexin,刘勇,Wu, Jingjing.Characterization of Dicaffeoylspermidine Derivatives from Wolfberry as Potent and Selective Inhibitors of Human Cytochrome P450 46A1 In vitro.[J],Current drug metabolism,2024,24(2):124-130
- [9]吕新.Wang, Zhe,夏杨柳,姜丽丽,刘勇,Jiang, Lili; Liu.王珍,尹航.Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronyltransferase (UGT) 1A1[J],CURRENT DRUG METABOLISM,2024,25(3):197-204
- [10]Lv, Xin.Wang, Zhe,Wang, Zhen,Yin, Hang,夏杨柳,姜丽丽,刘勇.Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.[J],Chemico-biological interactions,381:110574